PHARMACEUTICAL COMPOSITIONS CONTAINING SULPHONIC ACID DERIVATIVES

A naphthalenesulfonic acid or quinolinesulfonic acid of formula (I), wherein A is N or a CR8 formula group, where R8 is H, OH, NR10OR11, independently from one another, where R10 and R11 represent H or C1-C6 alkyl or a group of formula NH-CO-R12, where R12 is C1-C6 alkyl or C6-C10 aryl; R1 and R2 re...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Hauptverfasser: VALVERDE LOPEZ SERAFIN, BANFI TOSI BEATRIZ MARIA, LOZANO PUERTO ROSA MARIA, SANCHEZ CUEVAS PEDRO, GIMENEZ GALLEGO GUILLERMO
Format: Patent
Sprache:eng
Schlagworte:
Online-Zugang:Volltext bestellen
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
container_end_page
container_issue
container_start_page
container_title
container_volume
creator VALVERDE LOPEZ SERAFIN
BANFI TOSI BEATRIZ MARIA
LOZANO PUERTO ROSA MARIA
SANCHEZ CUEVAS PEDRO
GIMENEZ GALLEGO GUILLERMO
description A naphthalenesulfonic acid or quinolinesulfonic acid of formula (I), wherein A is N or a CR8 formula group, where R8 is H, OH, NR10OR11, independently from one another, where R10 and R11 represent H or C1-C6 alkyl or a group of formula NH-CO-R12, where R12 is C1-C6 alkyl or C6-C10 aryl; R1 and R2 represent H or SO3R9, independently from one another, where R9 is H, ammonium or a cation of an alkali or alkaline-earth metal; R3 is H or OH; and R4, R5, R6 and R7 represent H, an NR10R11 or NH-CO-R12 group, independently from one another; on the condition that (i) at least one of R1 or R2 is SO3R9, and (ii) at least one of R4, R5, R6 or R7 is an NR10R11 or NH-CO-R12 group, or their pharmaceutically acceptable salts; and a pharmaceutically acceptable excipient.
format Patent
fullrecord <record><control><sourceid>epo_EVB</sourceid><recordid>TN_cdi_epo_espacenet_US2009076140A1</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><sourcerecordid>US2009076140A1</sourcerecordid><originalsourceid>FETCH-epo_espacenet_US2009076140A13</originalsourceid><addsrcrecordid>eNrjZHAM8HAM8nV0dg0N8XR29FFw9vcN8A_2DPH09wsGcvxCHD39PP3cFYJDfQI8_P08nRUcnT1dFFxcgzzDHEM8w1yDeRhY0xJzilN5oTQ3g7Kba4izh25qQX58anFBYnJqXmpJfGiwkYGBpYG5maGJgaOhMXGqAMH2LFY</addsrcrecordid><sourcetype>Open Access Repository</sourcetype><iscdi>true</iscdi><recordtype>patent</recordtype></control><display><type>patent</type><title>PHARMACEUTICAL COMPOSITIONS CONTAINING SULPHONIC ACID DERIVATIVES</title><source>esp@cenet</source><creator>VALVERDE LOPEZ SERAFIN ; BANFI TOSI BEATRIZ MARIA ; LOZANO PUERTO ROSA MARIA ; SANCHEZ CUEVAS PEDRO ; GIMENEZ GALLEGO GUILLERMO</creator><creatorcontrib>VALVERDE LOPEZ SERAFIN ; BANFI TOSI BEATRIZ MARIA ; LOZANO PUERTO ROSA MARIA ; SANCHEZ CUEVAS PEDRO ; GIMENEZ GALLEGO GUILLERMO</creatorcontrib><description>A naphthalenesulfonic acid or quinolinesulfonic acid of formula (I), wherein A is N or a CR8 formula group, where R8 is H, OH, NR10OR11, independently from one another, where R10 and R11 represent H or C1-C6 alkyl or a group of formula NH-CO-R12, where R12 is C1-C6 alkyl or C6-C10 aryl; R1 and R2 represent H or SO3R9, independently from one another, where R9 is H, ammonium or a cation of an alkali or alkaline-earth metal; R3 is H or OH; and R4, R5, R6 and R7 represent H, an NR10R11 or NH-CO-R12 group, independently from one another; on the condition that (i) at least one of R1 or R2 is SO3R9, and (ii) at least one of R4, R5, R6 or R7 is an NR10R11 or NH-CO-R12 group, or their pharmaceutically acceptable salts; and a pharmaceutically acceptable excipient.</description><language>eng</language><subject>HUMAN NECESSITIES ; HYGIENE ; MEDICAL OR VETERINARY SCIENCE ; PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES ; SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS ORMEDICINAL PREPARATIONS</subject><creationdate>2009</creationdate><oa>free_for_read</oa><woscitedreferencessubscribed>false</woscitedreferencessubscribed></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><linktohtml>$$Uhttps://worldwide.espacenet.com/publicationDetails/biblio?FT=D&amp;date=20090319&amp;DB=EPODOC&amp;CC=US&amp;NR=2009076140A1$$EHTML$$P50$$Gepo$$Hfree_for_read</linktohtml><link.rule.ids>230,308,780,885,25564,76547</link.rule.ids><linktorsrc>$$Uhttps://worldwide.espacenet.com/publicationDetails/biblio?FT=D&amp;date=20090319&amp;DB=EPODOC&amp;CC=US&amp;NR=2009076140A1$$EView_record_in_European_Patent_Office$$FView_record_in_$$GEuropean_Patent_Office$$Hfree_for_read</linktorsrc></links><search><creatorcontrib>VALVERDE LOPEZ SERAFIN</creatorcontrib><creatorcontrib>BANFI TOSI BEATRIZ MARIA</creatorcontrib><creatorcontrib>LOZANO PUERTO ROSA MARIA</creatorcontrib><creatorcontrib>SANCHEZ CUEVAS PEDRO</creatorcontrib><creatorcontrib>GIMENEZ GALLEGO GUILLERMO</creatorcontrib><title>PHARMACEUTICAL COMPOSITIONS CONTAINING SULPHONIC ACID DERIVATIVES</title><description>A naphthalenesulfonic acid or quinolinesulfonic acid of formula (I), wherein A is N or a CR8 formula group, where R8 is H, OH, NR10OR11, independently from one another, where R10 and R11 represent H or C1-C6 alkyl or a group of formula NH-CO-R12, where R12 is C1-C6 alkyl or C6-C10 aryl; R1 and R2 represent H or SO3R9, independently from one another, where R9 is H, ammonium or a cation of an alkali or alkaline-earth metal; R3 is H or OH; and R4, R5, R6 and R7 represent H, an NR10R11 or NH-CO-R12 group, independently from one another; on the condition that (i) at least one of R1 or R2 is SO3R9, and (ii) at least one of R4, R5, R6 or R7 is an NR10R11 or NH-CO-R12 group, or their pharmaceutically acceptable salts; and a pharmaceutically acceptable excipient.</description><subject>HUMAN NECESSITIES</subject><subject>HYGIENE</subject><subject>MEDICAL OR VETERINARY SCIENCE</subject><subject>PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES</subject><subject>SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS ORMEDICINAL PREPARATIONS</subject><fulltext>true</fulltext><rsrctype>patent</rsrctype><creationdate>2009</creationdate><recordtype>patent</recordtype><sourceid>EVB</sourceid><recordid>eNrjZHAM8HAM8nV0dg0N8XR29FFw9vcN8A_2DPH09wsGcvxCHD39PP3cFYJDfQI8_P08nRUcnT1dFFxcgzzDHEM8w1yDeRhY0xJzilN5oTQ3g7Kba4izh25qQX58anFBYnJqXmpJfGiwkYGBpYG5maGJgaOhMXGqAMH2LFY</recordid><startdate>20090319</startdate><enddate>20090319</enddate><creator>VALVERDE LOPEZ SERAFIN</creator><creator>BANFI TOSI BEATRIZ MARIA</creator><creator>LOZANO PUERTO ROSA MARIA</creator><creator>SANCHEZ CUEVAS PEDRO</creator><creator>GIMENEZ GALLEGO GUILLERMO</creator><scope>EVB</scope></search><sort><creationdate>20090319</creationdate><title>PHARMACEUTICAL COMPOSITIONS CONTAINING SULPHONIC ACID DERIVATIVES</title><author>VALVERDE LOPEZ SERAFIN ; BANFI TOSI BEATRIZ MARIA ; LOZANO PUERTO ROSA MARIA ; SANCHEZ CUEVAS PEDRO ; GIMENEZ GALLEGO GUILLERMO</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-epo_espacenet_US2009076140A13</frbrgroupid><rsrctype>patents</rsrctype><prefilter>patents</prefilter><language>eng</language><creationdate>2009</creationdate><topic>HUMAN NECESSITIES</topic><topic>HYGIENE</topic><topic>MEDICAL OR VETERINARY SCIENCE</topic><topic>PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES</topic><topic>SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS ORMEDICINAL PREPARATIONS</topic><toplevel>online_resources</toplevel><creatorcontrib>VALVERDE LOPEZ SERAFIN</creatorcontrib><creatorcontrib>BANFI TOSI BEATRIZ MARIA</creatorcontrib><creatorcontrib>LOZANO PUERTO ROSA MARIA</creatorcontrib><creatorcontrib>SANCHEZ CUEVAS PEDRO</creatorcontrib><creatorcontrib>GIMENEZ GALLEGO GUILLERMO</creatorcontrib><collection>esp@cenet</collection></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext_linktorsrc</fulltext></delivery><addata><au>VALVERDE LOPEZ SERAFIN</au><au>BANFI TOSI BEATRIZ MARIA</au><au>LOZANO PUERTO ROSA MARIA</au><au>SANCHEZ CUEVAS PEDRO</au><au>GIMENEZ GALLEGO GUILLERMO</au><format>patent</format><genre>patent</genre><ristype>GEN</ristype><title>PHARMACEUTICAL COMPOSITIONS CONTAINING SULPHONIC ACID DERIVATIVES</title><date>2009-03-19</date><risdate>2009</risdate><abstract>A naphthalenesulfonic acid or quinolinesulfonic acid of formula (I), wherein A is N or a CR8 formula group, where R8 is H, OH, NR10OR11, independently from one another, where R10 and R11 represent H or C1-C6 alkyl or a group of formula NH-CO-R12, where R12 is C1-C6 alkyl or C6-C10 aryl; R1 and R2 represent H or SO3R9, independently from one another, where R9 is H, ammonium or a cation of an alkali or alkaline-earth metal; R3 is H or OH; and R4, R5, R6 and R7 represent H, an NR10R11 or NH-CO-R12 group, independently from one another; on the condition that (i) at least one of R1 or R2 is SO3R9, and (ii) at least one of R4, R5, R6 or R7 is an NR10R11 or NH-CO-R12 group, or their pharmaceutically acceptable salts; and a pharmaceutically acceptable excipient.</abstract><oa>free_for_read</oa></addata></record>
fulltext fulltext_linktorsrc
identifier
ispartof
issn
language eng
recordid cdi_epo_espacenet_US2009076140A1
source esp@cenet
subjects HUMAN NECESSITIES
HYGIENE
MEDICAL OR VETERINARY SCIENCE
PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS ORMEDICINAL PREPARATIONS
title PHARMACEUTICAL COMPOSITIONS CONTAINING SULPHONIC ACID DERIVATIVES
url https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-01-05T07%3A12%3A28IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-epo_EVB&rft_val_fmt=info:ofi/fmt:kev:mtx:patent&rft.genre=patent&rft.au=VALVERDE%20LOPEZ%20SERAFIN&rft.date=2009-03-19&rft_id=info:doi/&rft_dat=%3Cepo_EVB%3EUS2009076140A1%3C/epo_EVB%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_id=info:pmid/&rfr_iscdi=true